Clinical pharmacokinetics of ibuprofen. The first 30 years.
about
Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum periodIbuprofen for Alzheimer's diseaseOral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum periodNon-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic PericarditisSmall-molecule-induced Rho-inhibition: NSAIDs after spinal cord injuryMeloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteersIngestion of low-dose ibuprofen following resistance exercise in postmenopausal womenBioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers.The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamolEffect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humansA multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adultsCombined acetaminophen and ibuprofen for pain relief after oral surgery in adults: a randomized controlled trial.Pharmacokinetics of intravenous ibuprofen: implications of time of infusion in the treatment of pain and fever.Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.Cytochrome P450 2C8 pharmacogenetics: a review of clinical studiesTiming of Ibuprofen Use and Musculoskeletal Adaptations to Exercise Training in Older AdultsPharmGKB summary: ibuprofen pathways.Population pharmacokinetics of high dose ibuprofen in cystic fibrosis.Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use.Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteersInteraction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug.Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlEnantioselective pharmacokinetics of ibuprofen and involved mechanisms.Pharmacogenetics of analgesic drugsPain management for dentists: the role of ibuprofen.Non-steroidal anti-inflammatory drugs do not influence the urinary testosterone/epitestosterone glucuronide ratio.Metabolic profiling and population screening of analgesic usage in nuclear magnetic resonance spectroscopy-based large-scale epidemiologic studies.Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment.Pharmacogenetics of nonsteroidal anti-inflammatory drugs.Pharmacokinetic Properties of Intravenous Ibuprofen in Healthy Chinese Volunteers.Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months.Electrospun PLGA Nanofiber Scaffolds Release Ibuprofen Faster and Degrade Slower After In Vivo Implantation.How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity.Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs.Analgesic Efficacy of a New Immediate-Release/Extended-Release Formulation of Ibuprofen: Results From Single- and Multiple-Dose Postsurgical Dental Pain Studies.Cholesterol expels ibuprofen from the hydrophobic membrane core and stabilizes lamellar phases in lipid membranes containing ibuprofen.Ibuprofen blood plasma levels and onset of analgesia.Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers.Explaining the acetaminophen-ibuprofen analgesic interaction using a response surface model.
P2860
Q24193261-2593945B-BF8B-4884-8E33-DE6051D59B60Q24248782-83DD170A-BE6C-49AA-8797-20B7769D1640Q26471110-6E72CD87-E014-41E5-AC8A-0340DFA7F383Q26749687-35E070F1-B811-4ABC-82C2-16A80F2B7DB8Q27025964-182D14F5-5E04-48B3-B141-73F87337FEA8Q28168971-4BC0C6FE-5FE5-4CCE-992B-9C8EE7B1A864Q30457751-3122F71D-8819-4B7F-9293-3ED5C2B98CE1Q33517240-8481F390-EF04-43C0-B2DB-6CD3C9E65897Q33625366-06119CB7-18E6-4EF5-ABBA-AE48073E9026Q33655485-0B451787-669E-4F3D-90A0-482DEEBD9770Q34027088-5EE12A74-835D-478D-B5FB-CA3183147C1CQ34087882-FF3AC1CE-941B-454D-9E1D-9492E8947630Q34252982-F193C704-7D4E-4715-AA03-923020B6A5C2Q34517223-C915657E-2E69-47E4-B168-956C4731D381Q35003605-81205A68-2FBF-4ACF-94A5-CADCAE5CCD49Q35025003-552D538F-B5B1-4B5D-85C7-9E9518CDF6BBQ35164718-79B14A52-4CAE-4AEB-8E70-F8CC522921AAQ35274875-8378C925-CCB5-406E-AC6B-1BC8BBEDD898Q35803721-B5469242-B2B5-45C0-BE39-B3A2C7691D05Q35825392-A40FE875-4B50-4F6B-B5AF-46B921902591Q35846717-1D9DF776-2894-4B14-BF64-EF3B7A1D46C0Q35996458-63C328F1-DCE0-4A99-A142-D285FB73645CQ36061826-F28B754F-1846-465D-895C-9D0C403CB42DQ36110592-7C9ADDF2-0E7B-4688-B7D2-219E08E7BCFDQ36148700-82449011-9A54-48F5-A78B-D97498A8F4D3Q36847720-3193DE00-A87B-4283-B2BF-C2B8DDA96B46Q37304218-2F06B6E0-4A6F-480B-B763-8812B5CF7C88Q37440655-4D8D0C5A-A870-4F57-9FA0-57F4C9C34B29Q38050316-3BE1AC11-1136-4D6C-A1BC-43BFDB4A7477Q38388493-2AD0088C-72C1-43C6-B925-12124705D407Q38682570-D07D817A-82A7-4D59-9219-031781C1BFA5Q38707717-5B39969E-9C63-49F6-88E4-2E7BC73FCBF1Q38811685-B5F5BCFB-7DB9-40EA-98E4-D1608BC664B4Q38827332-78985968-8A85-4CD9-A985-31225F05C7EBQ39168414-AA193C31-728A-4CA6-AEBC-38874A97CE0EQ39190121-A66ED4C9-1760-420C-A00A-D95F4C6C442EQ39237721-CD340079-5FAD-41CD-8A42-AFF9A94A103FQ39665168-4FB2CE52-B735-4FFF-BAB1-064806CC60CEQ39666861-B364A2E7-8EAE-4DB0-B386-8129F4871668Q39733241-88C11839-5843-46EB-B559-DF79247A2957
P2860
Clinical pharmacokinetics of ibuprofen. The first 30 years.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@ast
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@en
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@nl
type
label
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@ast
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@en
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@nl
prefLabel
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@ast
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@en
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@nl
P1476
Clinical pharmacokinetics of ibuprofen. The first 30 years.
@en
P2093
P304
P356
10.2165/00003088-199834020-00002
P577
1998-02-01T00:00:00Z
P6179
1046787691